Surveillance of natural acquired antibodies to Haemophilus influenzae type b among children in Cairo-Egyptian.

Hum Antibodies

Antibody laboratory, Protein Research Department, Genetic Engineering and biotechnology Research institute (GEBRI), Mubarak City for Scientific Research and Technology Applications, New Borg EL Arab, Alexandria, Egypt.

Published: April 2006

AI Article Synopsis

Article Abstract

In Egypt, the incidence of invasive Haemophilus influenzae type b (Hib) disease is not common and the vaccine is still not included into the national immunization program. The aim of this study was to evaluate the natural immunity to Hib in healthy children at Egyptian capitol (Cairo). One hundred and two children were enrolled in our study of age one month to 15 year. Anti-capsular polysaccharide (PRP) of Hib specific IgM and IgG antibody concentrations were estimated using enzyme immunoassay. The majority (64.7%, 75.5%) of children had a protective levels>or=15 microg/ml of specific antibodies (IgM and IgG). Fortunately, a total of 95.5% of the children under 5 years old had a protective level. Our result will provide evidence that in Egypt capitol, the natural immunity against Hib can be acquired at an early age.

Download full-text PDF

Source

Publication Analysis

Top Keywords

haemophilus influenzae
8
influenzae type
8
natural immunity
8
immunity hib
8
igm igg
8
children
5
surveillance natural
4
natural acquired
4
acquired antibodies
4
antibodies haemophilus
4

Similar Publications

Risk Factors and Outcomes Associated With Polymicrobial Infection in Community-Acquired Pneumonia.

Arch Bronconeumol

January 2025

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain; University of Barcelona, Barcelona, Spain; Ciber de Enfermedades Respiratorias (Ciberes), Barcelona, Spain. Electronic address:

Background: Polymicrobial pneumonia is a concern for clinicians due to its association with increased disease severity. Determining the prevalence of polymicrobial pneumonia and identifying patients who have an increased risk of this aetiology is important for the management of CAP patients. Here we describe the clinical characteristics and outcomes of adult hospitalized patients with CAP, and identify the risk factors related to polymicrobial pneumonia and specifically to 30-day mortality.

View Article and Find Full Text PDF

Background: The primary purpose of this study was to detect the pathogen species using targeted next-generation sequencing (tNGS) to investigate the characteristics of community-acquired pneumonia (CAP)-related pathogens in children in Xiantao city, Hubei province, China.

Methods: A total of 1,527 children with CAP were prospectively recruited from our hospital between May 2022 and February 2023. Information on age and sex was collected from the medical records.

View Article and Find Full Text PDF

Based on the inhibitory potencies from earlier reported tetrazole thioether analogs, we now describe the synthesis and inhibition of pyrazole-based inhibitors of -succinyl-l,l-2,6-diaminopimelic acid desuccinylase (DapE) from (DapE). The most potent pyrazole analog bears an aminopyridine amide with an IC of 17.9 ± 8.

View Article and Find Full Text PDF

Background: The COVID-19 pandemic has significantly altered the etiological spectrum and epidemiological characteristics of pediatric respiratory diseases, and a profound understanding of these changes is crucial for guiding clinical treatment. The purpose of this study is to analyze the etiological patterns and epidemiological features of pathogens in bronchoalveolar lavage fluid (BALF) from children with pediatric lower respiratory tract infections (LRTIs) after the COVID-19 pandemic, with the aim of providing effective therapeutic evidence for clinical practice.

Methods: This study enrolled pediatric patients diagnosed with LRTIs who were treated and underwent BALF pathogen detection at our hospital from June 1, 2023, to June 1, 2024.

View Article and Find Full Text PDF

: Acute otitis media (AOM) is a common pediatric infection worldwide and is the primary basis for pediatric primary care visits and antibiotic prescriptions in children. Current licensed vaccines have been incompletely ineffective at reducing the global burden of AOM, underscoring a major unmet medical need. The complex etiology of AOM presents additional challenges for vaccine development, as it can stem from multiple bacterial species including , , and .

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!